Treatment for symptomatic melanoma brain metastases remains challenging, with limited efficacy from current standard immunotherapies like anti–PD-1 and anti-CTLA4.
2025
Common Virus Improves Melanoma Treatment Response, Reduces Side Effects
A common virus carried by approximately half of adults worldwide may improve outcomes for melanoma patients receiving immunotherapy while also protecting against severe treatment-related side effects and limiting the spread, according to new research from the University of Oxford.
CHOICE study doesn’t diminish sunscreen’s importance in melanoma capital of the world, advocates say
A new report from consumer advocacy group CHOICE has found only four out of 20 popular sunscreen products actually meet their claims of sun protection.
Looking Ahead: What’s on the Horizon in Advanced Melanoma
Emerging therapies and treatment approaches in melanoma